Skip to main content

Articles

Page 1 of 8

  1. In Switzerland, the influenza vaccination is recommended for high-risk groups and people who have contact with high-risk groups. Since 2015, Swiss pharmacists are allowed to vaccinate healthy adults after acqu...

    Authors: Dominik Stämpfli, Adrian Martinez-De la Torre, Sophie Du Pasquier, Danielle Stegmann, Andrea Brügger and Andrea M. Burden

    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:57

    Content type: Research

    Published on:

  2. Coronavirus disease (COVID-19) is an infectious disease caused by a newly discovered coronavirus. The nature of healthcare providers’ occupation puts them at an increased risk of getting any contagious disease...

    Authors: Abdullah Algunmeeyn, Faris El-Dahiyat, Mohammad Mitib Altakhineh, Mohammad Azab and Zaheer-Ud-Din Babar

    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:53

    Content type: Research

    Published on:

  3. With a scientific background from filoviruses, paramyxoviruses, SARS-CoV, and MERS-CoV, remdesivir entered into the COVID-19 battle to become one of the favorable therapeutic candidates with potential antivira...

    Authors: Vesa Halimi, Armond Daci, Nevenka Ridova, Irina Panovska-Stavridis, Milena Stevanovic, Venko Filipce, Aleksandar Dimovski and Aleksandra Grozdanova

    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:61

    Content type: Commentary

    Published on:

  4. During the COVID-19 pandemic, the Lebanese government has taken the proactive anticipatory measure to minimize the infection rates. Despite the pivotal role of the pharmacists working in hospital settings, hos...

    Authors: Rony M. Zeenny, Elsy Ramia, Youssef Akiki, Souheil Hallit and Pascale Salameh

    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:54

    Content type: Research

    Published on:

  5. The COVID-19 pandemic has unleashed unprecedented and complex public policy issues. One that has emerged as a challenge for many countries globally is how to ensure the efficient and effective procurement of q...

    Authors: Jillian Clare Kohler and Tom Wright

    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:58

    Content type: Commentary

    Published on:

  6. Regulatory inspection of private drug shops in Uganda is a mandate of the Ministry of Health carried out by the National Drug Authority. This study evaluated how this mandate is being carried out at national, ...

    Authors: Arthur Bagonza, Stefan Peterson, Andreas Mårtensson, Henry Wamani, Phyllis Awor, Milton Mutto, David Musoke, Linda Gibson and Freddy Eric Kitutu

    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:55

    Content type: Research

    Published on:

  7. The Caribbean Regulatory System is a centralized medicine assessment procedure established to serve the needs of the Member States of the CARICOM region. In order to better understand the effectiveness and eff...

    Authors: Lawrence Liberti, Rian Marie Extavour, Prisha Patel and Neil McAuslane

    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:56

    Content type: Research

    Published on:

  8. Maintaining an efficient and effective inventory management system ensures a reliable supply of laboratory commodities. The aim of this study was, therefore, to assess the performance of inventory management f...

    Authors: Abdi Befekadu, Waqtola Cheneke, Dereje Kebebe and Tadesse Gudeta

    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:49

    Content type: Research

    Published on:

  9. To strengthen appropriate medicine use (AMU) including the prescribing and dispensing quality at public sector health facilities in Uganda, the Ministry of Health introduced a multipronged approach known as th...

    Authors: Birna Trap, Moses N. Sembatya, Monica Imi, Morries Seru, Anita K. Wagner and Dennis Ross-Degnan

    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:48

    Content type: Research

    Published on:

  10. Iranian government has introduced multiple healthcare system reforms during the last 30 years aiming at improving accessibility and affordability of care. Pharmaceutical products are one of the major sources o...

    Authors: Saman Zartab, Nasrin Nassiri Koopaei, Hadi Abbasian, Mansur Nassiri Koopaei and Nasser Nassiri Koopaei

    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:50

    Content type: Research

    Published on:

  11. Most pharmacists agree that continuing education (CE) programs positively affect their practice and increase their knowledge, with computer-based courses being their preferred type of CE (60.6%). The route to ...

    Authors: Souheil Hallit, Samah Tawil, Hala Sacre, Clara Rahme, Aline Hajj and Pascale Salameh

    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:44

    Content type: Research

    Published on:

  12. This commentary describes the contributions of a Dutch pharmacist who contributed in a unique manner to the development of community pharmacy practice in Europe, to the evolution of practice-based research and...

    Authors: F. Alves da Costa, M. Henman, C. Hughes, H. Leufkens, Z. Babar, J. McElnay and M. Schulz

    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:51

    Content type: Obituary

    Published on:

  13. Amiodarone is known for its efficacy as an antiarrhythmic agent; however, its extensive side-effect profile requires careful selection of patients and frequent monitoring. The purpose of this study was to eval...

    Authors: Bander Ahmed Albassam, Nouf Mohammed Almutairi, Sarah Fahad Aldosari and Hind Saleh Almodaimegh

    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:37

    Content type: Research

    Published on:

  14. In March 2020, the World Health Organization (WHO) declared the coronavirus infectious disease as a pandemic referred to as COVID-19. As an essential service, community pharmacists have been enacting a key rol...

    Authors: Iman A. Basheti, Razan Nassar, Muna Barakat, Rajaa Alqudah, Rana Abu Farha, Tareq Muqatash, Samar Thiab and Bandana Saini

    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:62

    Content type: Research

    Published on:

  15. Empathy is the cornerstone of the relationship between the healthcare provider and the patient. In Lebanon, no studies have investigated the factors associated with empathy among community pharmacists. Hence, ...

    Authors: Eva Hobeika, Souheil Hallit, Hala Sacre, Sahar Obeid, Aline Hajj and Pascale Salameh

    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:32

    Content type: Research

    Published on:

  16. Universal access to high quality essential medicines is critical to sustainable development (SDG 3.8). However low- and middle-income countries struggle to ensure access to all medicines on their national esse...

    Authors: Petra Brhlikova, Karen Maigetter, Jude Murison, Amon G. Agaba, Jonans Tusiimire and Allyson M. Pollock

    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:31

    Content type: Research

    Published on:

  17. Resistant strains of bacteria are rapidly emerging with increasing inappropriate use of antibiotics rendering them less efficacious. Self-purchasing of antibiotics particularly for viral infections is a key dr...

    Authors: Zikria Saleem, Mohamed Azmi Hassali, Brian Godman, Munazzah Fatima, Zeenia Ahmad, Areeba Sajid, Inaam Ur Rehman, Muhammad Umer Nadeem, Zaida Javaid, Madeeha Malik and Azhar Hussain

    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:26

    Content type: Research

    Published on:

  18. Since SARS-CoV2 was declared a Public Health Emergency of International Concern, those tasked with the stewardship of public health at a global, regional, and local level—policymakers, politicians, scientists, dr...

    Authors: Jerome Amir Singh and Rafaella Ravinetto

    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:47

    Content type: Commentary

    Published on:

  19. There is limited published data form Pakistan on treatment success rate among extrapulmonary tuberculosis (EPTB) patients. The aim of this study was to assess clinical form, treatment outcomes, and identify th...

    Authors: Muhammad Atif, Razia Fatima, Nafees Ahmad and Zaheer-Ud-Din Babar

    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:35

    Content type: Research

    Published on:

  20. The coronavirus disease 2019 (COVID-19) impact on the mental health of healthcare workers is extremely detrimental. It is imperative that the psychological health of all healthcare workers be protected. Howeve...

    Authors: Ali Elbeddini, Cindy Xin Wen, Yasamin Tayefehchamani and Anthony To

    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:46

    Content type: Commentary

    Published on:

  21. Drug repositioning is the scientific strategy of investigating existing drugs for additional clinical indications. The advantages of drug repositioning are that it benefits patients and that it adds new indica...

    Authors: A. B. Bayoumy, N. K. H. de Boer, A. R. Ansari, F. Crouwel and C. J. J. Mulder

    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:45

    Content type: Review

    Published on:

  22. Potentially inappropriate prescribing (PIP) is associated with the incidence of adverse drug reactions, drug-related hospitalization and other negative outcomes in older adults. After hospitalization, older ad...

    Authors: Muhammad Eid Akkawi, Mohamad Haniki Nik Mohamed and Mohd Aznan Md Aris

    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:39

    Content type: Research

    Published on:

  23. High prices of pharmaceutical products are an increasing challenge in high- and low-income countries. Governments in many countries have implemented pricing policies to ensure affordability of medicines to pat...

    Authors: David Tordrup, Hendrika A. van den Ham, Julie Glanville and Aukje K. Mantel-Teeuwisse

    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:22

    Content type: Study Protocol

    Published on:

  24. The novel coronavirus disease 2019 (COVID-19) pandemic is a global challenge. Improving public awareness about preventive measures and disseminating appropriate information about COVID-19 has a critical role i...

    Authors: Ruwidah Bonyan, Aseel Fuad Al-Karasneh, Faris El-Dahiyat and Ammar Abdulrahman Jairoun

    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:43

    Content type: Research

    Published on:

  25. Coronavirus disease 2019 (COVID-19) is an infectious disease that has become a global pandemic. COVID-19 is spreading in Africa, and Zimbabwe has not been spared. The cases in Zimbabwe are mainly from imported...

    Authors: B. Dzingirai, C. M. J. Matyanga, T. Mudzviti, M. Siyawamwaya and D. Tagwireyi

    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:42

    Content type: Review

    Published on:

  26. The latest outbreak of Covid-19 pandemic has placed a significant effect on health care system around the world. This article discusses the role of pharmacists in Saudi Arabia during the current Covid-19 pande...

    Authors: Ajaz Ahmad, Khalid M. Alkharfy, Ziyad Alrabiah and Abdulaziz Alhossan

    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:41

    Content type: Commentary

    Published on:

  27. Pharmacies in Europe have undergone considerable changes in their regulation over the last decades, also regarding nonprescription medicines (NPMs). In 2001, selected NPMs were released for sale outside pharma...

    Authors: Solveig Nordahl Jacobsen, Simone Eggert Møller-Jensen and Sofia Kälvemark Sporrong

    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:29

    Content type: Research

    Published on:

  28. The response to emergency public health challenges such as HIV, TB, and malaria has been successful in mobilising resources and scaling up treatment for communicable diseases. However, many of the remaining ch...

    Authors: Tamara Hafner, Marlon Banda, Jillian Kohler, Zaheer-Ud-Din Babar, Murray Lumpkin, Mojisola Christianah Adeyeye, Emmanuel Nfor, Francis Aboagye-Nyame and Javier Guzman

    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:38

    Content type: Commentary

    Published on:

  29. Experiential education is a core element in developing the ability of pharmacy students to apply theory to practice, solve problems, and acquire standard pharmacist competencies. To achieve this goal, precepto...

    Authors: Abeer Zeitoun, Hala Sacre, Souheil Hallit, Rony M. Zeenny, Georges Sili and Pascale Salameh

    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:21

    Content type: Commentary

    Published on:

  30. In the fight against COVID-19, frontline health workers have been vital to keeping the pandemic at bay, but recognition of individual professions’ efforts have been inconsistent at all levels. Pharmacists arou...

    Authors: Ali Elbeddini, Thulasika Prabaharan, Sarah Almasalkhi and Cindy Tran

    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:36

    Content type: Commentary

    Published on:

  31. In Malaysia, for more than a decade, dipeptidyl peptidase-4 inhibitors (DPP-4i) are among the oral antidiabetic medications used as monotherapy or in combination to manage type II diabetes mellitus (T2DM). The...

    Authors: Woh Yon Mak, Jivanraj R. Nagarajah, Hannah Abdul Halim, Anitha Ramadas, Zulsairi Mohd Pauzi, Lay Ting Pee and Nirmala Jagan

    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:34

    Content type: Research

    Published on:

  32. SARS-CoV2 is dramatically impacting the global population. Worldwide, pharmacists are changing their roles and being increasingly recognized for their role as essential service providers. This commentary provi...

    Authors: Filipa Alves da Costa, Vivian Lee, Silvana Nair Leite, Maria Dolores Murillo, Tom Menge and Sotiris Antoniou

    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:12

    Content type: Commentary

    Published on:

  33. Data regarding prolonged length of hospital stay (PLOS) and in-hospital mortality are paramount to evaluate efficiency and quality of surgical care as well as for rational resource utilization, allocation, and...

    Authors: Gosaye Mekonen Tefera, Beshadu Bedada Feyisa, Gurmu Tesfaye Umeta and Tsegaye Melaku Kebede

    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:24

    Content type: Research

    Published on:

  34. An amendment to this paper has been published and can be accessed via the original article.

    Authors: Ali Elbeddini, Aniko Yeats and Stephanie Lee

    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:30

    Content type: Correction

    Published on:

    The original article was published in Journal of Pharmaceutical Policy and Practice 2020 13:18

  35. In 2015, the drive-through pharmacy was first introduced in Queen Elizabeth Hospital (QEH), Malaysia as one of the pharmacy value-added services. Therefore, it is imperative to review the service for further a...

    Authors: Jerry Ee Siung Liew, Aizan Adifarhan bin Abdul Gapar and Lik Ting Shim

    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:27

    Content type: Research

    Published on:

  36. Access to safe, effective, quality and affordable essential medicines for all is a central component of Universal Health Coverage (UHC). However, the availability of quality medicines in peripheral healthcare ...

    Authors: August Kuwawenaruwa, Fabrizio Tediosi, Brigit Obrist, Emmy Metta, Fiona Chiluda, Karin Wiedenmayer and Kaspar Wyss

    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:25

    Content type: Research

    Published on:

  37. Antibiotic resistance poses a great threat to global health, especially in low- and middle-income countries with a high infectious disease burden and limited resources. In spite of regulations, antibiotics are...

    Authors: Mohammad Abdul Matin, Wasif Ali Khan, Mohammad Mahbubul Karim, Sabeena Ahmed, Johannes John-Langba, Osman A. Sankoh, Margaret Gyapong, John Kinsman and Heiman Wertheim

    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:20

    Content type: Research

    Published on:

  38. The coronavirus disease (COVID-19) pandemic has placed enormous pressures on the Canadian healthcare system. Patients are expected to stay home in order to contain the spread of the virus, but understandably h...

    Authors: Ali Elbeddini and Aniko Yeats

    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:23

    Content type: Commentary

    Published on:

  39. The affordability of essential medicines is a challenge in achieving Universal Health Coverage (UHC). One of The Lancet Commission’s recommendations on financing of essential medicines is to ensure governments...

    Authors: Velisha Ann Perumal-Pillay and Fatima Suleman

    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:17

    Content type: Research

    Published on:

  40. Amid COVID-19 Crisis, reporting adverse drug reactions (ADRs) and medical device incidents (MDIs) to Health Canada or health authorities in every country is crucial for monitoring medication safety and improving ...

    Authors: Ali Elbeddini, Aniko Yeats and Stephanie Lee

    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:18

    Content type: Commentary

    Published on:

    The Correction to this article has been published in Journal of Pharmaceutical Policy and Practice 2020 13:30

  41. This commentary aims to elaborate challenges in the regulatory approaches for accessing and investigating COVID-19 potential therapies either with off-label use, compassionate use, emergency use or for clinica...

    Authors: Vesa Halimi, Armond Daci, Simona Stojanovska, Irina Panovska-Stavridis, Milena Stevanovic, Venko Filipce and Aleksandra Grozdanova

    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:16

    Content type: Commentary

    Published on:

  42. There is plenty of evidence to support that women leaders are needed in the health and pharmaceutical sectors, although most of the leadership positions in global health are predominantly occupied by men. This...

    Authors: Nadia Bukhari, Mehr Manzoor, Huma Rasheed, Bismah Nayyer, Madeeha Malik and Zaheer-Ud-Din Babar

    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:15

    Content type: Commentary

    Published on:

  43. The use of quality injectable oxytocin effectively prevents and treats postpartum hemorrhage, the leading cause of maternal death worldwide. In low- and middle-income countries (LMICs), characteristics of oxyt...

    Authors: Peter Lambert, Michelle P McIntosh, Mariana Widmer, Lawrence Evans, Megan Rauscher, Rutendo Kuwana, Fiona Theunissen, Beth Yeager and Helen Petach

    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:14

    Content type: Review

    Published on:

  44. The world currently faces unprecedented health challenges as COVID-19 poses a huge threat to health systems, economies and societies as we know it. The events of the current COVID-19 pandemic have further emph...

    Authors: Amy Hai Yan Chan, Victoria Rutter, Diane Ashiru-Oredope, Chloe Tuck and Zaheer-Ud-Din Babar

    Citation: Journal of Pharmaceutical Policy and Practice 2020 13:13

    Content type: Commentary

    Published on:

Annual Journal Metrics